What are the precautions with proton pump inhibitor use for reflux disease?

被引：2

作者：

Mospan, Cortney M. ^{[1
,2
]}

机构：

[1] E Tennessee State Univ, Bill Gatton Coll Pharm, Pharm Practice, Johnson City, TN 37614 USA

[2] Univ Charitable Pharm, Columbus, OH USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2015年 / 28卷 / 12期

关键词：

gastroesophageal reflux disease; proton pump inhibitor; comorbidities; older adults; clopidogrel; fractures; THERAPY; SAFETY;

D O I：

10.1097/01.JAA.0000473372.47749.16

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Gastroesophageal reflux disease (GERD) affects 10% to 20% of the western world's population. Current treatment guidelines recommend proton pump inhibitors (PPIs) as first-line therapy. Although PPIs cause mild adverse reactions, they pose risks, particularly for older adults with comorbidities.

引用

页码：23 / 26

页数：3

共 50 条

[41] Endoscopy-negative reflux disease: What is the value of a proton-pump inhibitor test in everyday clinical practice?
Juul-Hansen, P
Rydning, A
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (12) : 1200 - 1203
[42] Prospective Evaluation of Duodenogastroesophageal Reflux in Gastroesophageal Reflux Disease Patients Refractory to Proton Pump Inhibitor Therapy
Kunsch, S.
Neesse, A.
Linhart, T.
Nell, C.
Gress, T. M.
Ellenrieder, V.
DIGESTION, 2012, 86 (04) : 315 - 322
[43] Proton pump inhibitor resistance in the treatment of laryngopharyngeal reflux
Amin, MR
Postma, GN
Johnson, P
Digges, N
Koufman, JA
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2001, 125 (04) : 374 - 378
[44] Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
Lazarus, Benjamin
Chen, Yuan
Wilson, Francis P.
Sang, Yingying
Chang, Alex R.
Coresh, Josef
Grams, Morgan E.
JAMA INTERNAL MEDICINE, 2016, 176 (02) : 238 - 246
[45] Proton Pump Inhibitor Treatment Has Little Effects on Secretion of Saliva in Patients with Proton Pump Inhibitor-Responsive Mild Reflux Esophagitis and Non-Erosive Reflux Disease
Hoshikawa, Yoshimasa
Momma, Eri
Hoshino, Shintaro
Kawami, Noriyuki
Kitasako, Yuichi
Ikeda, Masaomi
Iwakiri, Katsuhiko
DIGESTION, 2023, 104 (03) : 187 - 192
[46] Additional Mosapride to Proton Pump Inhibitor for Gastroesophageal Reflux Disease: A Meta-Analysis
Nishizawa, Toshihiro
Mori, Kiyoto
Yoshida, Shuntaro
Ebinuma, Hirotoshi
Toyoshima, Osamu
Suzuki, Hidekazu
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 11
[47] Work productivity and response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease
Wahlqvist, Peter
Ducrotte, Philippe
Jones, Roger
Liker, Harley
GASTROENTEROLOGY, 2007, 132 (04) : A350 - A350
[48] Washed microbiota transplantation reduces proton pump inhibitor dependency in nonerosive reflux disease
Zheng, Ya-Mei
Chen, Xian-Yun
Cai, Jie-Yi
Yuan, Yu
Xie, Wen-Rui
Xu, Jia-Ting
Xia, Harry Hua-Xiang
Zhang, Min
He, Xing-Xiang
Wu, Li-Hao
WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (06) : 513 - 522
[49] Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease
Michele Cicala
Sara Emerenziani
Michele Pier Luca Guarino
Mentore Ribolsi
World Journal of Gastroenterology, 2013, (39) : 6529 - 6535
[50] Persistent gastroesophageal reflux disease symptoms on standard proton-pump inhibitor therapy
Sontag, SJ
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2002, 31 (04) : S77 - +

← 1 2 3 4 5 →